Changes in hepatic and renal Doppler ultrasonography: Current standard therapy in dogs with congestive heart failure

Çağatay Esin1, Murat Güzel1

  • 1Department of Veterinary Internal Medicine, Faculty of Veterinary Medicine, Ondokuz Mayis University, Samsun, Turkey.

Open Veterinary Journal
|November 7, 2025
PubMed

Insights

Congestive heart failure (CHF) in dogs impairs kidney and liver blood flow. Standard CHF treatment, including pimobendan, improved these hemodynamic changes within two weeks, suggesting therapeutic benefits for cardiorenal and cardiohepatic function.

Area of Science:

  • Veterinary Medicine
  • Cardiology
  • Nephrology

Background:

  • Congestive heart failure (CHF) compromises cardiac output, leading to systemic vascular changes and organ dysfunction, particularly affecting the kidneys and liver.
  • Dogs with advanced heart failure exhibit significant hemodynamic alterations in vital organs.

Purpose of the Study:

  • To assess the impact of standard CHF therapy on renal and hepatic hemodynamics in dogs.
  • To evaluate the recovery of kidney and liver vascular function during treatment.

Main Methods:

  • Doppler ultrasonography was employed to measure renal and hepatic hemodynamic indices in 15 dogs with CHF (Stages C/D) and 10 healthy controls.
  • Dogs received standard therapy (pimobendan, enalapril, furosemide) for four weeks, with assessments at baseline and weeks 1, 2, and 4.

Main Results:

  • Dogs with CHF showed significantly deteriorated hepatic and renal resistive indices and renal pulsatility index compared to healthy controls.
  • Hemodynamic abnormalities in the kidney and liver began to show improvement after two weeks of treatment.
  • Echocardiography confirmed heart failure diagnosis, and Doppler findings correlated with disease severity.

Conclusions:

  • CHF significantly impairs renal and hepatic vascular hemodynamics in dogs.
  • Standard CHF therapy demonstrates potential to reverse or improve cardiorenal and cardiohepatic dysfunction associated with the condition.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
779
Assessing Blood pressure using a doppler ultrasound01:19

Assessing Blood pressure using a doppler ultrasound

To obtain accurate blood pressure measurements in clinical settings, especially when traditional methods are insufficient, healthcare professionals utilize the Doppler ultrasound technique. This method uses high-frequency sound waves to detect blood flow within the arteries, which is crucial for patients with conditions that complicate circulatory system assessment.
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
2.3K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
243
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
207
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
305